11 July 2019
French healthcare system reform: The final steps of the legislative process are expected soon
www.twobirds.com/en/news/articles/2019/france/french-healthcare-system-reform-the-final-steps-of-the-legislative-process-are-expected-soon

The Bill of the Law on the organization and transformation of the French healthcare system at the French parliament, adoption of the final version is expected for the end of July.

08 May 2019
Manufacturing and stockpiling waiver set to limit rights of holders of SPCs for medicines
www.twobirds.com/en/news/articles/2019/global/manufacturing-and-stockpiling-waiver-set-to-limit-rights-of-holders-of-spcs-for-medicines

On 17 April 2019, the European Parliament approved, by a large majority, an amendment of the Regulation on Supplementary Protection Certificates ("SPCs").

02 July 2019
Transfer of value: amendments to the French “anti-gift” provisions by the draft Health Act
www.twobirds.com/en/news/articles/2019/global/transfer-of-value-amendments-to-the-french-anti-gift-provisions-by-the-draft-health-act

The French so-called “anti-gift” provisions strictly frame the conditions under which companies in the health sector are allowed to provide advantages, in cash or in kind, to healthcare professionals ("HCPs”)

18 March 2019
French Legal Framework for the exchange of health data by secured health messaging systems
www.twobirds.com/en/news/articles/2019/france/french-legal-framework-for-the-exchange-of-health-data-by-secured-health-messaging-systems

Before the entry into force of the GDPR on May 25th 2018, healthcare professionals and facilities and professionals in medico-social sectors empowered by law in France had to comply with the provisions stated in the ...

30 May 2019
International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

18 April 2019
Bird & Bird Germany advises Aphria on its tender for the cultivation, processing and delivery of cannabis for medical purposes
www.twobirds.com/en/news/press-releases/2019/germany/bird-bird-beraet-aphria-im-vergabeverfahren-cannabis

We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.

23 April 2020
COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry
www.twobirds.com/en/news/articles/2020/global/covid-19-our-series-of-regulatory-legislation-trackers-for-the-life-sciences-and-healthcare-industry

COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships ...

17 March 2020
COVID-19: UK Public Health Perspectives
www.twobirds.com/en/news/articles/2020/uk/covid-19-uk-public-health-perspectives

As Novel Coronavirus (COVID-19) continues to spread across the globe, in an effort to prepare for all eventualities, on 10 February 2020, the UK Government passed into law The Health Protection (Coronavirus) Regulations ...